This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient safety. Infrequently, we see medical technology innovation of a paradigmatic nature that changes the way physicians approach disease states and dramatically improve results. So, again, innovation is great.
Positron joins forces with the coalitions founding members, Bracco Diagnostics , CDL Nuclear Technologies and Siemens Healthcare who have come together to promote federal policies that advance health outcomes for patients with cardiovascular disease and improve the availability of cardiac PET diagnostics throughout the United States.
The NeuSight PET-CT is an innovative, inexpensive PET-CT system making it ideal for both cardiology and oncology clinical studies having superior data acquisition, with identification technology for improved scanning speed and accuracy. NeuSight PET-CT is a versatile scanner and an ideal solution for SPECT providers adopting the PET modality.
vii Similarly, recent increases in Medicare reimbursement rates for CCTA are a positive step towards making this technology more accessible. This innovative technology maximizes operational efficiency, enhances staff expertise, and delivers better patient outcomes, making it a wise long-term investment.
Harnessing Collaborative Innovation to Combat Cardiometabolic Risk Building on the foundation in Part 1 , explore real-world examples of how creative partnerships transform cardiorenal metabolic risk management. It further exemplifies the patient education and empowerment strategies.
Below, we will explore 3 use cases of EHR reporting and demonstrate how cardiologists and clinicians can improve patient outcomes, increase efficiency, and improve financial performance. The reporting features found in a comprehensive cardiology EHR platform can truly improve workflow and increase practice efficiency.
With the recent changes to MIPS reporting requirements, healthcare providers seek innovative solutions to streamline their reporting processes while maximizing incentives and improving patient care. Additionally, the 2024 final rule retains the methodology for measuring scores and achieving points with no notable alterations.
The national registry reports play a vital role in collecting the data so that new methods can be innovated for the treatment of growing diseases. Leveraging the reports, patient outcomes can be improved, and hospitals can provide improved patient care. Creating registry reports these days has become extremely simple.
G”) leverages new innovations, including AI, to achieve previously unimaginable health and business outcomes. As noted by HIMSS24 planners, Renner brings invaluable insights from the forefront of cloud computing, and his expertise and commitment to innovation make him a compelling voice in the industry.
The Cordella platform is the first and only PA pressure-guided platform to offer comprehensive patient management using daily PA pressure and vital signs from home to guide therapeutic management and improve patient outcomes. Reimbursement for implantation and ongoing management through existing reimbursement pathways. "At
They often lack essential features, such as cardiovascular-specific templates and robust diagnostic reporting, critical for improving patient outcomes. These benefits directly translate into better efficiency, higher-quality care, and reduced administrative burden, allowing your team to focus more on patient outcomes.
At GEMMS, we are dedicated to advancing efficient cardiology care through innovative technology solutions. Our GEMMS ONE EHR is designed to meet the unique demands of cardiology practices, streamlining operations while improving patient outcomes. This means quicker reimbursements and better financial health for your practice.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content